Featured Publications
Prevalence of Missing Data in the National Cancer Database and Association With Overall Survival
Yang DX, Khera R, Miccio JA, Jairam V, Chang E, Yu JB, Park HS, Krumholz HM, Aneja S. Prevalence of Missing Data in the National Cancer Database and Association With Overall Survival. JAMA Network Open 2021, 4: e211793. PMID: 33755165, PMCID: PMC7988369, DOI: 10.1001/jamanetworkopen.2021.1793.Peer-Reviewed Original ResearchConceptsNational Cancer DatabaseNon-small cell lung cancerOverall survivalCell lung cancerCancer DatabaseMedical recordsLung cancerProstate cancerBreast cancerPatient recordsComplete dataRetrospective cohort studyCohort studyCancer RegistryCommon cancerVariables of interestHigh prevalenceMAIN OUTCOMEPatientsClinical advancementReal-world data sourcesCancerPrevalenceSurvivalHeterogeneous differences
2024
Comparative Effectiveness of SBRT
Shen J, Sritharan D, Yu J, Aneja S. Comparative Effectiveness of SBRT. 2024, 455-467. DOI: 10.1007/978-3-031-67743-4_33.Peer-Reviewed Original ResearchStereotactic body radiation therapyEffect of stereotactic body radiation therapyAlternative to other treatment modalitiesStereotactic body radiation therapy treatmentLong-term follow-up of patientsFollow-up of patientsLong-term follow-upTreatment of brainOligometastatic diseaseRadiation therapyTreatment of cancerRetrospective seriesTreatment modalitiesRenal cancerCost-effectiveness studiesDatabase analysisCancerTreatmentProstateTherapy
2022
Deep learning algorithm to predict pathologic complete response to neoadjuvant chemotherapy for breast cancer prior to treatment.
Choi R, Joel M, Hui M, Aneja S. Deep learning algorithm to predict pathologic complete response to neoadjuvant chemotherapy for breast cancer prior to treatment. Journal Of Clinical Oncology 2022, 40: 600-600. DOI: 10.1200/jco.2022.40.16_suppl.600.Peer-Reviewed Original ResearchPathologic complete responseNeoadjuvant chemotherapyBreast cancerComplete responseBreast MRIImproved disease-free survivalDisease-free survivalStage breast cancerPre-treatment predictionSubsets of ageNAC initiationOverall survivalPCR rateTreatment initiationUnnecessary toxicityTumor sizeSingle institutionDisease groupPatient levelPrognostic dataChemotherapyPatientsDiscordant predictionsCancerTotal test set
2015
Minimally Invasive Surgery and External Beam Radiation Therapy Selection for Prostate Cancer Varies Significantly by Health Insurance Status
Bledsoe T, Park H, Rutter C, Aneja S, Yu J. Minimally Invasive Surgery and External Beam Radiation Therapy Selection for Prostate Cancer Varies Significantly by Health Insurance Status. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e358-e359. DOI: 10.1016/j.ijrobp.2015.07.1461.Peer-Reviewed Original Research